Related Experiment Videos
Evaluation of the antipsychotic activity of an indole analogue, AL-1612
Current Therapeutic Research, Clinical and Experimental
|September 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Evaluation of the basophil activation test and skin prick testing for the diagnosis of sesame food allergy.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2018
A Sperm Spawn-Inducing Pheromone in the Silver Lip Pearl Oyster (Pinctada maxima).
Marine biotechnology (New York, N.Y.)·2018
Primordial germ cell migration in the yellowtail kingfish (Seriola lalandi) and identification of stromal cell-derived factor 1.
General and comparative endocrinology·2015
Prevalence and correlates of antinuclear antibodies in a Japanese community sample: a cross-sectional study.
Current therapeutic research, clinical and experimental·2026
Paclitaxel, carboplatin, and cetuximab induction chemotherapy for locally advanced head and neck squamous cell carcinoma: A retrospective evaluation of treatment outcomes and safety.
Current therapeutic research, clinical and experimental·2026
Potential interactions between creatine supplementation and prescription drugs: a narrative review and evidence-mapping perspective.
Current therapeutic research, clinical and experimental·2026
Dna aneuploidy and urothelial carcinoma: A meta-analysis.
Current therapeutic research, clinical and experimental·2026
U-Shaped Association Between Serum Vitamin B12 and All-Cause Mortality in Adults With Obesity in the United States: A Prospective Cohort Study.
Current therapeutic research, clinical and experimental·2026
Treatment satisfaction and patient preference for efanesoctocog alfa over previous hemophilia A treatment: Results from the XTEND-1 phase 3 clinical trial.
Current therapeutic research, clinical and experimental·2026
Next-generation nanocrystals of phytochemicals: overcoming bioavailability challenges and enabling targeted therapeutics.
Chemical communications (Cambridge, England)·2026